<![CDATA[Navigating Coverage and Cost: What Pharmacists Need to Know About Access to Non-Hormonal VMS Therapies]]>

Unraveling the FDA's CNPV and Expedited Review Programs

<![CDATA[Assessing Bleeding and Variceal Risk Before Anti-VEGF Therapy in HCC]]>

A Consumer Guide to Drug Formularies: Understanding the Fundamentals of Behavioral Health Medications

Un nuevo fármaco disminuye a la mitad los días de migraña en pacientes sin otras opciones

Un estudio del Hospital de Bellvitge demuestra que con el atogepant los enfermos experimentan una mejora significativa tras tres meses de tr

Personal Reflection on Using Proprietary Medical Devices for Diabetes Management

I wrote last month about my diabetes diagnosis this year and my difficult choice to wear a proprietary device (called a CGM) on my arm 24/7

Menopause legislation gains momentum across U.S. states to improve treatment access and insurance coverage

More than half of the states have introduced or passed menopause bills including requiring insurance companies to cover hormone therapy.